Company: XAIR
Filing Date: 2025-02-10
Form Type: 10-Q
Source: 0001493152-25-005678
Chunk: 25

Company: Beyond Air, Inc.
Filing Date: 2025-02-10
Form: 10-Q
Item: Part I, Item 1
Chunk 25
---
 - 
  
    U.S. government securities 
     -  
     16,388 
  
    Mutual fund (ultra-short-term income) 
     6,349  
     6,702 
  
    Total marketable securities 
    $6,349  
    $23,090 

    Total cash, cash equivalents, marketable securities and restricted cash 
    $11,182  
    $34,698 

     14 

BEYOND
AIR, INC. AND SUBSIDIARIES

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE
2 SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (continued)

The
following table summarizes the Company’s short-term marketable securities with unrealized gains and losses as of December 31, 2024,
aggregated by major security type:

 SUMMARY
OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED GAINS AND LOSSES

    (in thousands) 
    Fair Value  
    Unrealized Gains 
  
    Corporate debt securities 
    $-  
    $- 
  
    U.S. government securities 
     -  
     - 
  
    Mutual fund (ultra-short-term income) 
     6,349  
     15 
  
    Total short-term marketable securities 
    $6,349  
    $15 

The
following table summarizes our short-term marketable securities with unrealized gains and losses as of March 31, 2024, aggregated by
major security type:

    (in thousands) 
    Fair Value  
    Unrealized Gains 
  
    Corporate debt securities 
    $-  
    $- 
  
    U.S. government securities 
     16,388  
     117 
  
    Mutual fund (ultra-short-term income) 
     6,702  
     6 
  
    Total short-term marketable securities 
    $23,090  
    $123 

All
marketable securities are A- or higher rated. No marketable securities have maturities greater than 12 months. All investments are level
1 investments.

Segment
Reporting

Commencing
with the creation of Beyond Cancer in November 2021, the Company’s operations became classified into two segments, Beyond Air and
Beyond